| 摘要 |
<P>PROBLEM TO BE SOLVED: To provide an inhibitor for the onset and/or progress of liver cancer for a patient with liver cirrhosis who also has diabetes and/or has a BMI value of 25 or higher, and who has hepatitis C virus positive, or with decompensated cirrhosis. <P>SOLUTION: The inhibitor for the onset and/or progress of liver cancer includes three types of branched amino acids i.e. isoleucine, leucine and valine, or salts thereof as active ingredients, wherein a weight ratio of the three types of branched amino acids or the salts thereof is 1:1.5-2.5:0.8-1.7, and a dosage per day is 2g-50g. <P>COPYRIGHT: (C)2013,JPO&INPIT |
